Delivery Order SPE2DB20D3101-SPE2DB23FRGE4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,898.80 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The $10,648.27 fixed-price contract has an ultimate completion date of April 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,070.42 delivery order contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed-price pricing type and a completion date of November 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,455.59 firm fixed-price delivery order is for the supply of Eliquis 5mg tablets, a cardiovascular medication. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,602.20 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,895.39 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The $9,918.44 firm-fixed-price delivery order contract has a completion date of December 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award is a delivery order worth $16,085.11 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a medication used for cardiovascular health. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,136.52 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for the treatment of various cardiovascular conditions. The contract has an ultimate completion date of June 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,175.98 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for the treatment of various cardiovascular conditions. The contract has an ultimate completion date of April 4, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRGE4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Cencora, Inc., a major pharmaceutical distribution company. The $12,388.29 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used for the treatment of various cardiovascular conditions. The contract has an ultimate completion date of March 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract. The contract award did not have any set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 3/24/23 |